ArticleCancer immunology, immunotherapy : CII2026
Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial.
Amin Shahbaz Ghasabeh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.